SIRP&#945;Fc treatment targets human acute myeloid leukemia stem cells.

Galkin, Oleksandr; McLeod, Jessica; Kennedy, James A; Jin, Liqing; Mbong, Nathan; Wong, Mark; Uger, Robert A; Minden, Mark D; Danska, Jayne S; Wang, Jean C Y

SIRPαFc treatment targets human acute myeloid leukemia stem cells.

Galkin, Oleksandr; McLeod, Jessica; Kennedy, James A; Jin, Liqing; Mbong, Nathan; Wong, Mark; Uger, Robert A; Minden, Mark D; Danska, Jayne S; Wang, Jean C Y.

Affiliation

Galkin O; Princess Margaret Cancer Centre, University Health Network, Toronto, ON.
McLeod J; Princess Margaret Cancer Centre, University Health Network, Toronto, ON.
Kennedy JA; Princess Margaret Cancer Centre, University Health Network, Toronto, ON.
Jin L; Princess Margaret Cancer Centre, University Health Network, Toronto, ON.
Mbong N; Princess Margaret Cancer Centre, University Health Network, Toronto, ON.
Wong M; Trillium Therapeutics Inc., Mississauga, ON.
Uger RA; Trillium Therapeutics Inc., Mississauga, ON.
Minden MD; Princess Margaret Cancer Centre, University Health Network, University of Toronto.
Danska JS; Hospital for Sick Children, University of Toronto, Toronto, ON.
Wang JCY; Princess Margaret Cancer Centre, University Health Network, University of Toronto.

Haematologica ; 106(1): 279-283, 2021 01 01.

Article de En | MEDLINE | ID: mdl-32054659

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie aigüe myéloïde Limites: Humans Langue: En Journal: Haematologica Année: 2021 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google